总知道看后面在泪花将做我笑,但我未曾知道看后面在笑将做我啼声。 [translate] aB-cell non-Hodgkin's lymphoma B细胞non-Hodgkin的淋巴瘤 [translate] 英语翻译 日语翻译 韩语翻译 德语翻译 法语翻译 俄语翻译 阿拉伯语翻译 西班牙语翻译 葡萄牙语翻译 意大利语翻译 荷兰语翻译 瑞典语翻译 希腊语翻译 51La ...
aMy reality 我的现实 [translate] amost non-Hodgkin's lymphoma B cells 多数non-Hodgkin的淋巴瘤b细胞 [translate] 英语翻译 日语翻译 韩语翻译 德语翻译 法语翻译 俄语翻译 阿拉伯语翻译 西班牙语翻译 葡萄牙语翻译 意大利语翻译 荷兰语翻译 瑞典语翻译 希腊语翻译 51La ...
Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-ce... To analyze the outcome, including nonrelapse mortality (NRM), relapse rate (RR), progression-free survival (PFS), and overall survival (...
Mcl-1在B细胞非霍奇金淋巴瘤中的表达及临床意义 Expression and clinical significance of Mcl-1 in B cell non-Hodgkin's lymphoma
Non-Hodgkin lymphoma (NHL) is not a single disease entity, but rather a group of diseases, most of which are B cell in origin, though rare types of NHL are of T or natural killer cell origin. Several immunotherapeutic agents are available for the treatment of B-cell NHL, including the ...
Which cells will not be found in Hodgkin's lymphoma? A. Reed-Sternberg cells B. Mirror image cells C. Lacunar cells D. Popcorn cells E. Oat cells(肺小细胞癌) 相关知识点: 试题来源: 解析 E.Oat cells (肺小细胞癌) 反馈 收藏
2. Xinfeng Chen, Yu Ping, Ling Li, et al. CD19/BCMA DUAL-TARGETING FASTCAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA: AN UPDATE. 2024 EHA. Abstract: P1181. 3. Jiaqi Guo,...
Intensive multiagent chemotherapy has resulted in remarkably improved event-free survival (EFS), approaching 80% in children with B non-Hodgkin lymphomas (B-NHL) [1,2]. In contrast, conventional treatment of childhood B-NHL in St. Petersburg, especially in advanced stages, has continued to be...
In this study, we examined the function of the CD95 antigen in B-cell–derived non-Hodgkin’s lymphoma (NHL), a malignant disease of mature B cells. Membrane CD95 molecules were found to be constitutively expressed in a large number of NHL, including mantle cell (MCL, n = 10), ...
Treatment recommendations for patients with diffuse large B-cell lymphoma (DLBCL) begin with evaluating the extent of the disease, performance status of the patient, and histologic subtypes. Treatment of localized and advanced disease varies considerably. Below is a general treatment algorithm for DLBCL...